Combined ratio rose to 91.4% on weaker underwriting

The combined ratio rose to 91.4% from 88.6%, and underwriting profit fell to $28.7m from $36.7m. The claims ratio excluding large events rose to 50.2% from 46.3%, and large-event claims expense rose to $13.9m from $9.7m. The expense ratio improved to 37.0% from 39.3%, only partly offsetting the claims pressure.

Premium growth was modest. Gross written premium grew 5% to around $350m, and net earned premium rose to $332.7m from $323.3m. Net investment income collapsed to $0.2m from $5.3m.

Reported profit before tax was $28.5m versus $20.3m, with NPAT of $18.7m versus $11.9m, helped by a lower tax rate. Operating cash flow rose to $98.6m from $18.9m and the cash balance rose to $116.1m from $80.1m.

A combined ratio of 91.4% remains profitable, but the move from 88.6% — driven by a higher loss ratio and elevated large-event costs — is the central read on the year. For an insurer, this matters more than the headline profit because underwriting quality determines whether premium growth converts to durable earnings.

The investment result was a marginal contributor. Net investment income of just $0.2m versus $5.3m removed a meaningful prop from group profit. With underwriting also softer, the underlying profit engine narrowed materially, leaving non-recurring items and a lower tax rate to do more of the work in the reported numbers.

Tax rate moved in NPAT's favour. The effective tax rate dropped to 32.1% from 39.1%, widening NPAT growth relative to PBT growth and contributing to a -16.7 percentage-point gap between them. That flatters the bottom-line print rather than reflecting operating improvement.

Half-year context shows HY21 NPAT of $11.5m, meaning implied second-half NPAT was about $7.2m — roughly 38% of the full year. That shape is consistent with the lift in large-event claims and weaker investment result, and it argues against extrapolating first-half momentum into FY22.

Solvency was 271% versus 287% a year earlier — still well above regulatory minimums, but lower. The release notes $56.6m of capital above the target solvency margin.

Operating cash flow of $98.6m versus $18.9m is the most striking line of the result, but the year-on-year jump is largely non-recurring in character. Pre-lease free cash flow of $95.5m sits within the supplied historical range (mean $87.4m, range $7.5m–$142.8m), so on a multi-year view the cash outcome is not unusual; it is the prior-year comparison that flatters the conversion ratio. Capex remains negligible at 0.7% of revenue.

On reported earnings, two effects support the PBT and NPAT improvement that are not core underwriting: a lower effective tax rate (32.1% versus 39.1%) and the absence of a prior-period charge that depressed FY20. Strip those out and the operating read is softer than the headline — consistent with the combined-ratio deterioration. The dividend is supported by cash and solvency in absolute terms, but the supplied historical baseline shows the implied payout ratio against NPAT running above prior years' average of around 70%, which warrants caveating given the same comparability flag now affects the underlying basis.

This briefing cannot assess whether catastrophe-event frequency will normalise in FY22 or remain elevated.